Once you start taking Enzalutamide/Enzalutamide (Anchortan), can you stop taking it at will?
Enzalutamide/Enzalutamide (Enzalutamide) is a drug used to treat metastatic castration-resistant prostate cancer (mCRPC) and has potent anti-tumor effects. It blocks the growth of tumor cells by inhibiting the transcriptional activity of androgen receptors and inhibiting the effects of androgens. However, many patients and doctors are very concerned about the discontinuation of drugs, especially whether they can be stopped at will during treatment.
Enzalutamide is not a conventional "voluntary withdrawal" drug. If patients stop taking medication at will without medical guidance, it may lead to rapid deterioration of the condition, especially in the treatment of malignant tumors such as prostate cancer. As a long-term drug, enzalutamide usually takes time to show its effects. Once the drug is stopped, the patient's condition may rebound quickly, and the cancer cells may resume activity, even leading to further progression of the disease. Therefore, once you start taking enzalutamide, you should continue to use it under the guidance of a doctor, especially during the treatment period. If you want to stop taking the drug, you must go through the evaluation and decision of a professional doctor.
In some cases, if the side effects of enzalutamide are intolerable, doctors may recommend suspending or adjusting treatment, but this decision must be based on the patient's specific situation and take into account the risks of discontinuing the drug. If the patient develops serious adverse reactions or other health problems during treatment, the doctor will decide whether the drug needs to be changed or the dosage adjusted based on a comprehensive assessment. In addition, in some special cases, enzalutamide may need to be used in combination with other drugs, and the timing and method of drug discontinuation also need to be adjusted according to the combined treatment strategy.
In short, as an anti-tumor drug, the use of enzalutamide needs to strictly follow the doctor's recommendations, and patients should not stop taking the drug at will. The decision to discontinue medication must be evaluated by a professional doctor to ensure that it will not affect the treatment effect or worsen the condition.
Reference materials:https://www.xtandi.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)